Home » RESOURCES

| Resources

BILLING, CODING AND INDICATIONS

For information related to billing/coding please register and one of our team members will be in touch ASAP.

EDUCATIONAL MATERIALS

PATIENT EDUCATIONAL BROCHURE

View PDF ➞

PLACEMENT TIPS & STEPS

View PDF ➞

APOLLO AMNIOTIC MEMBRANE GRAFT BROCHURE

View PDF ➞

WHAT IS AMNIOTIC MEMBRANE THERAPY & WHY IMPLEMENT INTO THE PRACTICE

View PDF ➞

PLACEMENT VIDEO LIBRARY

PLACEMENT TECHNIQUE

PUTTING MEMBRANE IN CONTACT

PLACING ON PATIENT

PLACEMENT DEMONSTRATION

PLACEMENT TECHNIQUE

CASE STUDIES

AMNIOTIC MEMBRANE USE IN TREATING CORNEAL ABRASION DURING PREGNANCY

View PDF ➞

AMNIOTIC MEMBRANE FOR THE TREATMENT OF A CORNEAL CHEMICAL BURN

View PDF ➞

NEUROTROPHIC KERATITIS TREATMENT AND MANAGMENT, UTILIZING DEHYDRATED AMNIOTIC MEMBRANE

View PDF ➞

FILAMENTARY KERATITIS: PROTRACTED RESOLUTION FOLLOWING DEHYDRATED MEMBRANE PLACEMENT

View PDF ➞

AMNIOTIC MEMBRANE USE FOR HERPETIC CORNEAL ULCERATIONS

UTILIZING DEHYDRATED AMNIOTIC MEMBRANE

View PDF ➞

TESTIMONIALS

“Patient came in Wednesday with a large corneal erosion. I inserted amniotic membrane and sent him home. He returned Friday looking and feeling a lot better. Incredible results. That was a big erosion!”
CS, OD

“I saw the patient yesterday....one week after placement. To my surprise, not only did his cornea look better but the scarring that I was really concerned about seems to have abated! The patient just turned 90 this week!”
Dr. F, OD

TISSUE TRACKING FORM

Apollo amniotic membrane is regulated by FDA Regulations and Joint Commission Standards.1 Per these regulations and standards we have to track the tissue distributed to you and store those records for a minimum of 10 years. It is your responsibility, also per these regulations, to provide the end-user tracking information back to our distribution department for post-transplant tissue tracking. Please complete the below tissue tracking with the pertinent practice and patient information and click submit.

Bahram (Ben) Alavi
Founder and President

Bahram Alavi is the founder and president of Atlas Ocular, Inc. He has worked for over 20 years in the healthcare and medical device field and started his career at Medtronic. Mr. Alavi’s father was an expert and compassionate orthopedic surgeon and attending professor at Tehran University in Tehran Iran. He was the inspiration and spark which lead to Mr. Alavi’s interest in the biotechnology space. Mr. Alavi cites his father always saying, “no matter what you do in life, do it to the best of your ability”. This premise resonates throughout the culture of Atlas Ocular where the best people, quality technology, and superior customer service merge in providing an exceptional customer experience.

Samuel S. Stopak, M.D.
Medical Director

Dr. Stopak is graduate of George Washington University with a Bachelor of Science, Zoology. He earned his Doctor of Medicine from Emory University School of Medicine and completed an internship at Emory Affiliated Hospitals. His residency was at Georgetown University School of Medicine Department of Ophthalmology in Washington DC, where he was also name Associate Chief Resident on the Ophthalmology Residency Education Committee. In addition, he completed a fellowship at the University of Pittsburgh School of Medicine Department of Ophthalmology, specializing in Cornea and External Disease. In addition to his private practice Dr. Stopak has been appointed Clinical Assistant Professor and Director Cornea Services, Department of Ophthalmology George Washington University Medical Center. He is also a cornea consultant at Washington Hospital Center. He has been the president and chairman of the board at Eye Care Incorporated and in 1993 was president of the Washington DC Ophthalmological Society. Dr. Stopak has authored multiple publications and presentations and has been named to Washington DC’s “Top Doctor’s” list 7 years.